How certain medications help control appetite and insulin levels
Molecular mechanisms mediating metabolic benefits of glucagon-like peptide-1 receptor agonists
['FUNDING_R01'] · VANDERBILT UNIVERSITY · NIH-10987062
This study is looking at how a medication called liraglutide helps control hunger and insulin levels by understanding how it works in the brain and pancreas, which could lead to better treatments for diabetes and obesity.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY (nih funded) |
| Locations | 1 site (Nashville, UNITED STATES) |
| Trial ID | NIH-10987062 on ClinicalTrials.gov |
What this research studies
This research investigates the molecular mechanisms by which glucagon-like peptide-1 receptor (GLP-1R) agonists, such as liraglutide, help regulate appetite and insulin secretion. The study focuses on understanding how these medications interact with key nutrient sensing pathways in the brain and pancreas, particularly the mechanistic Target of Rapamycin Complex-1 (mTORC1). By exploring these interactions, the research aims to uncover the biological processes that lead to reduced food intake and improved metabolic health, which could ultimately enhance treatment options for diabetes and obesity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with obesity or type 2 diabetes who are seeking better management options for their condition.
Not a fit: Patients who do not have obesity or diabetes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for managing obesity and diabetes by improving our understanding of how GLP-1R agonists work.
How similar studies have performed: Previous research has shown promising results with GLP-1R agonists in managing weight and insulin levels, indicating that this approach has potential for further success.
Where this research is happening
Nashville, UNITED STATES
- VANDERBILT UNIVERSITY — Nashville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AYALA, JULIO E — VANDERBILT UNIVERSITY
- Study coordinator: AYALA, JULIO E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.